Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incretin Action in Physiology and Diabetes

NCT02550548 is registered in ClinicalTrials.gov with David D'Alessio, M.D. as lead sponsor.

NCT NCT02550548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02550548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incretin Action in Physiology and Diabetes
Lead sponsor
David D'Alessio, M.D.
Phase
Phase 1
Overall status
Completed
Start date
April 21, 2016
Completion date
April 16, 2021
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin secretion